Wells Fargo & Company Axogen, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Axogen, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 47,807 shares of AXGN stock, worth $702,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,807

Previous 50,285 4.93%

Holding current value

$702,284

Previous $405,000 14.57%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.67 - $8.06 $14,050 - $19,972	-2,478 Reduced 4.93%	47,807 $346,000
Q1 2024 May 10, 2024	BUY	$6.63 - $10.69 $67,897 - $109,476	10,241 Added 25.57%	50,285 $405,000
Q4 2023 Feb 09, 2024	BUY	$3.61 - $7.76 $12,266 - $26,368	3,398 Added 9.27%	40,044 $273,000
Q3 2023 Nov 13, 2023	SELL	$4.68 - $9.26 $157,116 - $310,876	-33,572 Reduced 47.81%	36,646 $183,000
Q2 2023 Aug 15, 2023	BUY	$8.5 - $10.38 $71,740 - $87,607	8,440 Added 13.66%	70,218 $641,000
Q1 2023 May 12, 2023	BUY	$7.53 - $10.95 $58,711 - $85,377	7,797 Added 14.44%	61,778 $583,000
Q4 2022 Feb 13, 2023	SELL	$9.44 - $13.09 $28 - $39	-3 Reduced 0.01%	53,981 $538,000
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $3,231 - $4,863	-397 Reduced 0.73%	53,984 $644,000
Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $150,557 - $215,390	-21,539 Reduced 28.37%	54,381 $445,000
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $111,985 - $165,047	-15,425 Reduced 16.89%	75,920 $603,000
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $223,520 - $406,400	-25,400 Reduced 21.76%	91,345 $855,000
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $262,900 - $374,930	17,262 Added 17.35%	116,745 $1.84 Million
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $369,065 - $487,249	20,734 Added 26.33%	99,483 $2.15 Million
Q1 2021 May 13, 2021	SELL	$17.18 - $22.6 $1 Million - $1.32 Million	-58,417 Reduced 42.59%	78,749 $1.6 Million
Q4 2020 Feb 09, 2021	BUY	$11.5 - $17.96 $15,019 - $23,455	1,306 Added 0.96%	137,166 $2.46 Million
Q3 2020 Nov 05, 2020	SELL	$10.62 - $13.12 $445,859 - $550,816	-41,983 Reduced 23.61%	135,860 $1.58 Million
Q2 2020 Aug 13, 2020	BUY	$7.35 - $10.81 $1.15 Million - $1.7 Million	157,112 Added 757.86%	177,843 $1.64 Million
Q1 2020 May 14, 2020	BUY	$8.38 - $17.34 $173,725 - $359,475	20,731 New	20,731 $215,000

Others Institutions Holding AXGN

# of Institutions

129

Shares Held

35.8M

Call Options Held

79.1K

Put Options Held

500

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $621M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Axogen, Inc. Transaction History